Abstract
Abstract
This article reports the case of a woman with chief complains of aching pain in the upper right of her abdomen, fatigue, and weakness. She had no medical history of any diseases, trauma, and other signs related to her complains. Both blood tests and abdominal ultrasonography revealed that she has been afflicted with nonalcoholic fatty liver disease (NAFLD). The medical procedure consisted of administering a polyphenolic flavonoid named silymarin, which have been pointed out that it has antioxidant, anti-fibrotic, and anti-inflammatory properties. After taking 30 days silymarin, her liver aminotransferase enzymes levels including alanine aminotransferase (ALT) and aspartate aminotransferase (AST), which are considered criteria to diagnose NAFLD, decreased. Therefore, this result unifies this notion that silymarin can be deemed as a therapeutic agent to be used in NAFLD patients.
Publisher
Research Square Platform LLC
Reference39 articles.
1. Nonalcoholic Fatty Liver Disease Cirrhosis: A Review of Its Epidemiology, Risk Factors, Clinical Presentation, Diagnosis, Management, and Prognosis;Li B;Can J Gastroenterol Hepatol,2018
2. Epidemiology of liver cirrhosis;Stasi C;Journal of clinical and experimental hepatology,2015
3. Liver cirrhosis;Schuppan D;Lancet,2008
4. Nonalcoholic fatty liver disease;Bayard M;Am Fam Physician,2006
5. The prevalence and etiology of elevated aminotransferase levels in the United States;Clark JM;The American Journal of Gastroenterology,2003